OHR PHARMACEUTICAL INC's ticker is and the CUSIP is 67778H950. A total of 3 filers reported holding OHR PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 4 | -92.0% | 0.00% | -100.0% |
| Q1 2018 | $15,000 | +66.7% | 50 | -2.0% | 0.00% | – |
| Q4 2017 | $9,000 | +350.0% | 51 | +410.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -94.7% | 10 | -87.7% | 0.00% | -100.0% |
| Q1 2017 | $19,000 | +58.3% | 81 | +30.6% | 0.00% | 0.0% |
| Q4 2016 | $12,000 | +500.0% | 62 | +24.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 50 | +212.5% | 0.00% | – |
| Q2 2016 | $1,000 | -88.9% | 16 | -65.2% | 0.00% | -100.0% |
| Q1 2016 | $9,000 | +200.0% | 46 | -17.9% | 0.00% | – |
| Q4 2015 | $3,000 | -93.0% | 56 | -70.5% | 0.00% | -100.0% |
| Q3 2015 | $43,000 | +138.9% | 190 | +475.8% | 0.00% | +50.0% |
| Q2 2015 | $18,000 | -45.5% | 33 | -50.0% | 0.00% | -50.0% |
| Q1 2015 | $33,000 | +3200.0% | 66 | +266.7% | 0.00% | – |
| Q4 2014 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 85,800 | $622,000 | 0.01% |
| Citadel Advisors | 6,600 | $48,000 | 0.00% |